trending Market Intelligence /marketintelligence/en/news-insights/trending/nrbl7fzz9okihsvyuawqsg2 content esgSubNav
In This List

Spectrum Pharmaceuticals appoints board member

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise


Spectrum Pharmaceuticals appoints board member

Henderson, Nev.-based Spectrum Pharmaceuticals Inc. added William Ashton to its board of directors.

Ashton was previously vice president for U.S. sales at Amgen Inc. His appointment expands the company's board to nine members.

Spectrum develops drug products for blood diseases and cancer.